Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (ADGM)
CUSIP: 00534B100
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 21,148,193
- Total 13F shares
- 10,801,797
- Share change
- -1,217,763
- Total reported value
- $11,342,157
- Price per share
- $1.05
- Number of holders
- 15
- Value change
- -$3,360,595
- Number of buys
- 8
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 00534B100?
CUSIP 00534B100 identifies ADGM - Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00534B100:
Top shareholders of ADGM - Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
46%
|
9,812,419
|
$25,316,041 | — | 30 Sep 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
6.3%
|
1,333,926
|
$3,441,529 | — | 30 Sep 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
1%
|
213,235
|
$550,146 | — | 30 Sep 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.99%
|
209,361
|
$540,151 | — | 30 Sep 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.7%
|
148,861
|
$384,061 | — | 30 Sep 2024 | |
| Shaolin Capital Management LLC |
13F
|
Company |
0.66%
|
140,000
|
$361,200 | — | 30 Sep 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.52%
|
110,571
|
$285,273 | — | 30 Sep 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
0.13%
|
27,000
|
$69,660 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
23,107
|
$59,616 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
760
|
$1,961 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
291
|
$751 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
19
|
$49 | — | 30 Sep 2024 | |
| Olav Bergheim |
3/4/5
|
CEO, Director |
—
class O/S missing
|
234,134
|
— | — | 31 Jul 2024 | |
| Hakon Bergheim |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
8,539
mixed-class rows
|
— | — | 31 Jul 2024 |
Institutional Holders of Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (ADGM) as of Q4 2024
As of 31 Dec 2024,
Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (ADGM) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,801,797 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Affinity Asset Advisors, LLC, RTW INVESTMENTS, LP, Shaolin Capital Management LLC, Opaleye Management Inc., JPMORGAN CHASE & CO, ADAR1 Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, and TORONTO DOMINION BANK.
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
12
Q4 2024 holders
15
Holder diff
3
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.